Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01989689 · ClinicalTrials.gov registry record · Phase 2
Etanercept and Vascular Function in Psoriasis
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT01989689 is a Phase 2 study that has completed, run by Emory University. The registered enrollment target is 24 participants.
The verdict
NCT01989689, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The investigators plan to measure the health of the vascular system of subjects taking Etanercept for the treatment of plaque psoriasis.
Interventions
- DRUG Placebo
- DRUG Etanercept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01989689
The ClinicalTrials.gov registry entry for NCT01989689 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01989689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01989689 about?
NCT01989689 is a clinical study titled "Etanercept and Vascular Function in Psoriasis". The investigators plan to measure the health of the vascular system of subjects taking Etanercept for the treatment of plaque psoriasis.
What is the current status of trial NCT01989689?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2010-08. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01989689?
The interventions under investigation include: Placebo (DRUG), Etanercept (DRUG).
Who is sponsoring clinical trial NCT01989689?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.